Inspire Medical Expects Strong Q4 FY21 Revenue Growth

  • Inspire Medical Systems Inc INSP expects Q4 FY21 revenue of $78.0 million - $78.4 million, up approximately 70% Y/Y and surpassing the consensus estimate of $65.84 million.
  • For FY21, the Company sees sales of $233.0 million - $233.4 million, an approximately 102% increase over FY20.
  • Inspire activated 81 new centers in the U.S. in Q4 FY21, bringing the total to 684 U.S. medical centers implanting Inspire therapy.
  • The Company also received FDA approval for the Inspire Bluetooth-enabled patient remote control during the quarter.
  • The Company will report its full financial results for 2021 on February 8, 2022.
  • Price Action: INSP shares closed at $232.65 on Tuesday.

Posted In: BriefsEarningsNewsGuidanceHealth CareGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.